Target intelligence / Profile preview

Immunoglobulin kappa variable region pseudogene 3 (IGKV3OR22-2)

Target: IGKV3OR22-2
Molecular classification: Other (Pseudogene), Immunoglobulin gene family, Immunoglobulin variable region, Not a receptor, enzyme, channel, transporter, or transcription factor

Overview

Immunoglobulin kappa variable region pseudogene 3 (IGKV3OR22-2) is a non-functional genetic element classified as a pseudogene within the human immunoglobulin kappa variable region locus[1][2][3]. Unlike functional immunoglobulin variable region genes, which encode the variable domains of immunoglobulin (antibody) light chains and participate in antigen recognition and diversity, pseudogenes such as IGKV3OR22-2 lack the ability to produce functional proteins due to mutations or deletions that disrupt normal gene expression and translation[2]. Pseudogenes may represent evolutionary relics of previously functional genes and do not serve direct biological or therapeutic roles. Their presence within the immunoglobulin gene loci does not affect drug target identification, functional annotation, or clinical biomarker use.

Other names: IGKV3/OR22-2IGKV3OR222IGKVP3immunoglobulin kappa variable region pseudogene 3IGKV3OR22-2

Mechanism of action

None (no drugs target this pseudogene; mechanisms relevant only to functional immunoglobulin genes)

Biological functions

None (pseudogene; does not code for functional protein)Related contextual function: Immunoglobulin variable regions are involved in antigen recognition—but functional genes, not pseudogenes.

Disease associations

None (not implicated in disease as a functional gene or direct biomarker)Pseudogenes sometimes have regulatory or evolutionary roles, but not directly as a therapeutic target.

Safety considerations

None (as a non-functional pseudogene, there are no direct therapeutic or safety issues)

Interacting drugs

None (pseudogene; not targeted by drugs)

Biomarkers

None known for patient selection or monitoring

Beyond the preview

Go deeper on Immunoglobulin kappa variable region pseudogene 3 (IGKV3OR22-2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin kappa variable region pseudogene 3 (IGKV3OR22-2).

Explore the full profile